Danielle Lloyd displays her weight loss after losing two from stress following shock cancer diagnosis that left her fearing she was 'going to die'

Danielle Lloyd has displayed her weight loss after losing two stone from stress following shock cancer diagnosis that left her fearing she was 'going to die'.
The model and TV host, 41, was diagnosed with the deadliest form of skin cancer, Melanoma, in February and was so terrified she struggled to eat and sleep.
Danielle, who is now cancer free, took to her Instagram on Sunday with before and after snaps of herself in underwear and showed off her shrinking frame.
She captioned the post: 'Following my recent skin cancer diagnosis, I've been committed to improving my overall well-being'.
It comes after Danielle told The Sun: 'Being a mum, I was trying to put a brave face on for everyone, but inside I've been crumbling. I was worried every single day that I was going to die.'
From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the Daily Mail's new Showbiz newsletter to stay in the loop.
Danielle shares Archie, 14, Harry, 13, and George, 11, with ex-husband Jamie O'Hara. She is mother to Ronnie, seven, and Autumn Rose, three, with husband Michael O'Neill.
Symptoms of melanoma include a new mole or changes to an existing mole, which is exactly what happened to the star, when she noticed one on her collarbone was changing shape.
After tragically losing a friend to bowel cancer the previous year, she knew it was worth investigating and visited her GP, who referred her onto a dermatologist who advised removal.
This took place in December, but Danielle had to wait an agonising nine weeks before she was diagnosed with melanoma.
Recalling her reaction, she said: 'I just burst into tears. I wasn't expecting it. When I heard the word 'cancer', I just thought, "That's it, I'm going to die."'
She then had to have the skin surrounding the mole removed as a preventative measure as doctors worked to establish whether or not the cancer had spread.
Danielle said she told her older kids who were old enough to understand that she had cancer but refrained from telling her younger children as she did not want them to jump to the worst case scenario.
Thankfully, eight weeks after her February procedure, Danielle was told she was cancer free.
Danielle shared a tearful video to Instagram in February which she revealed she had been diagnosed with cancer after noticing a change to one of her moles.
She then detailed the emotional moment she told her eldest sons Archie - who she welcomed with her ex-husband Jamie O'Hara - about her diagnosis.
Danielle revealed she hasn't told her two younger children - who she shares with her husband Michael O'Neill - because they wouldn't understand.
'I told the older three but not the younger two. Ronnie is at an age where he wouldn't really understand, he'd hear that word and think I was going to die,' she told Closer.
'It was difficult telling the older boys, Harry asked me if my hair was going to fall out.
'It's hard because they're still young, so I don't know if they fully understand - which is a good thing because I don't want to put a strain on them.'
Danielle also recalled the moment she was told she had skin cancer after she visited the doctors to get a 'very small' mole on her collarbone checked when she noticed it had changed shape.
It is not the first time Danielle has had a cancer scare as she was rushed to hospital in 2023 after suffering from heavy bleeding.
Doctors then discovered she had large cysts on her ovaries, but was thankfully told they were non-cancerous after undergoing a biopsy.
She also found a lump in her breast last year and was given the all-clear in October after a biopsy discovered the lump was benign.
What is malignant melanoma?
Malignant melanoma is a serious form of skin cancer that begins in melanocytes, cells found in the upper layer of skin that produce melanin, which gives skin its colour.
While less common that other types of skin cancer, it is more dangerous because of its ability to spread to other organs more rapidly if it is not treated at an early stage.
Symptoms
A new mole or a change in an existing mole may be signs of melanoma.
Melanomas can appear anywhere on your body, but they're more common in areas that are often exposed to the sun.
Some rarer types can affect the eyes, soles of the feet, palms of the hands or genitals.
Check your skin for any unusual changes. Use a mirror or ask a partner or friend to check any areas you cannot see.
In particular, look for:
Moles with an uneven shape or edges
Moles with a mix of colours
Large moles - melanomas often tend to be more than 6mm wide
Moles that change size, shape or colour over time
Causes
Ultraviolet (UV) light is the most common cause of melanoma. It comes from the sun and is used in sunbeds.
Melanoma is more common in older people, but younger people can also get it.
You're also more likely to get melanoma if you have:
Pale skin that burns easily in the sun
Red or blonde hair
Blue or green eyes
A large number of freckles or moles
Had a lot of sun exposure and you've had sunburn a lot in the past
Used sunbeds a lot
A history of skin cancer in your family or you've had skin cancer before
If you have black or brown skin, you have a lower chance of getting melanoma, but you can still get it.
Prevention
Staying safe in the sun is the best way to lower your chance of getting skin cancer (both melanoma and non-melanoma).
Do the following:
Stay out of the sun during the hottest part of the day (11am to 3pm in the UK)
Keep your arms and legs covered and wear a wide-brimmed hat and sunglasses that provide protection against ultraviolet (UV) rays
Use sunscreen with a sun protection factor (SPF) of at least 30 and at least 4-star UVA protection – make sure you reapply it regularly
Make sure babies and children are protected from the sun – their skin is much more sensitive than adult skin
Treatment
Melanoma skin cancer can often be treated. The treatment you have will depend on where it is, if it has spread and your general health.
Surgery is the main treatment for melanoma. Radiotherapy, medicines and chemotherapy are also sometimes used.
Surgery could involve removing the melanoma and an area of healthy skin around it, swollen lymph nodes if the cancer has spread to them and other parts of the body if it has spread to them.
If a large part of skin has to be removed, a skin graft might be needed which could see kin taken from another part of the body to cover the area where the melanoma was.
Radiotherpay is sometimes used to reduce the size of large melanomas and help control and relieve symptoms.
Targeted medicines and immotherapy are used to treat melanomas that can't be dealt with by surgery, or have spread to lymph glands or other parts of the body.
Chemotherapy, which kills cancer cells, is sometimes used to treat advanced melanoma when it has spread to another part of the body. It does not work as well as other treatments, but can be used if you are unable to have them.
How dangerous is it?
Generally for people with melanoma in England:
almost all people (almost 100%) will survive their melanoma for 1 year or more after they are diagnosed
around 90 out of every 100 people (around 90%) will survive their melanoma for 5 years or more after diagnosis
more than 85 out of every 100 people (more than 85%) will survive their melanoma for 10 years or more after they are diagnosed

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Sky News

11 minutes ago

• Sky News

Ex-classmates died after being treated at same mental health hospital - as concerns raised over more deaths

They were former classmates who both died after receiving care from the same mental health hospital three years apart. Warning: This article contains reference to suicide Multiple failings led to the death of 22-year-old Alice Figueiredo - who took her own life in July 2015 - and the NHS trust responsible for her care was charged with corporate manslaughter. Last week, following a months-long trial, the trust was found not guilty of that charge but was convicted of serious health and safety failings. Karis Braithwate, who had gone to school with Alice, also died in 2018, having been treated by the same NHS trust. Reports seen by Sky News detail a decade of deaths at North East London NHS Foundation Trust (NELFT), with coroners repeatedly raising concerns about the mental health services provided by the trust - in particular at Goodmayes Hospital in Ilford. Rushed assessments and neglect were often cited. One patient was marked as alive and well, even though he had taken his own life inside the hospital the previous day. Another patient told staff he was hearing voices telling him to kill himself, yet staff did not remove crucial items from his possession - items he would later use to take his own life. Karis, 24, was sent to Goodmayes Hospital after she tried to take her own life at a train station in October 2018. The next day, staff spent 27 minutes assessing her and a further two minutes confirming their conclusion. She was discharged from hospital in the afternoon. She then went to a nearby railway station and took her own life. Her death came less than an hour after she had left the hospital. Karis had been friends with Alice, her mother said. The pair had been classmates at the same school. Karis told her mother she was upset at being put on the same ward where Alice had taken her own life three years earlier. Her stepfather Mark Bambridge called Karis sweet and kind and said she often "struggled with life". He felt relief when she was taken to hospital, saying: "She was in a place where she would be taken care of." Karis's mother - who asked not to be named - said her daughter confided in her about the neglect she endured at the hospital. Karis told her mother that her carer would sleep when they were supposed to be watching over her and said she never felt safe. "She spoke of her belongings going missing, of being treated with indifference and disrespect, and of staff who showed little concern for her wellbeing," her mother said. Karis's mother said her daughter was failed by the hospital and the family was offered only a "hollow, superficial and indifferent 'apology' from the administration team of those who were meant to protect her". In the wake of the verdict in Alice's case, Karis's mother said: "I am holding Alice's family in my thoughts and praying they receive the justice they - and we - so clearly need and deserve." A spokesperson for NELFT called Karis's death a "profound tragedy" and said the trust had conducted an in-depth review of patient safety since 2018, "resulting in significant changes in the way we assess risk of suicide". "We train our staff to consider the trauma in a patient's history, rather than focusing solely on their current crisis," the spokesperson added. "This approach allows us to see the person behind the diagnosis, making it easier to identify warning signs and support safe recovery." The trust said it had also improved record-keeping and communication between emergency workers and mental health practitioners. The man marked as alive after he'd died Sky News looked at more than 20 prevention of future death reports, which are written by a coroner to draw attention to a matter in which they think action could be taken to prevent future deaths. Behind each report is a different person, but there are some strikingly similar themes - failure to carry out adequate risk assessments; issues sharing and recording information; neglect. One report said staff at Goodmayes Hospital "panicked and did not follow policy" in the wake of a man's death in 2021, instead writing that he was still alive when he had died the day before. Speaking in response at the time, the trust said it had written a "detailed action plan" to address concerns raised. Another report said one woman developed deep vein thrombosis after she was left to sit motionless in her room. She had not eaten or drunk anything in the two days before her death, and the trust was criticised for failing to record her food intake. Responding to the report at the time, the trust said it had implemented new policies to learn from her death. Issues stretched beyond Goodmayes Hospital and spanned the entire NHS trust. One man was not given any community support and overdosed after his access to medication was not limited. Another man, a father of three, was detained under the Mental Health Act but released from Goodmayes after just a few hours. The 39-year-old was found dead two weeks later after being reported missing by his family. At his inquest, a coroner raised concerns about the lack of a detailed assessment around him, with a junior doctor saying he was the only doctor available for 11 wards and 200 patients. 'Don't kill yourself on my shift' It has been 10 years since Alice took her own life inside the walls of Goodmayes Hospital. But current patients say the issues haven't gone away. Teresa Whitbread said her 18-year-old granddaughter Chantelle was a high suicide risk but she still managed to escape from the hospital "20 times". "I walked in one day and said, 'Where is Chantelle?', and no one could tell me," she told Sky News. On another occasion, Chantelle managed to get into the medical room and stabbed herself and a nurse with a needle. She said one nurse told her granddaughter: "Don't kill yourself on my shift. Wait until you go home and kill yourself." Teresa grew emotional as she talked about her granddaughter, once a vibrant young girl and avid boxer, whose treatment is now managed by community services. "It's made her worse," Teresa said of Chantelle's experience at Goodmayes Hospital. "There's no care, there's no care plan, there's no treatment." The NEFLT said it could not comment on specific cases but added that "patient safety is our absolute priority, and we work closely with our patients and their families to ensure we provide compassionate care tailored to their needs". Chantelle's family say she is a shell of her former self and have begged mental health services not send her back to Goodmayes. "Something has to change, and if it doesn't change, [the hospital] needs to be closed down," Teresa said. "Because people are not safe in there."

The Independent

36 minutes ago

• The Independent

Weight loss pill shows promise in new trial

A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.

Daily Mail​

an hour ago

• Daily Mail​

Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons

A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.